Skip to main content

Advertisement

Log in

Role of NF-κB as a Prognostic Marker in Breast Cancer : A Pilot Study in Indian Patients

  • Original Article
  • Published:
Indian Journal of Surgical Oncology Aims and scope Submit manuscript

Abstract

The nuclear factor κB (NF-κB) is a superfamily of transcription factors. It plays an important role in development & progression of cancer. This study was conducted in a tertiary care centre to investigate the significance of NF-κB as a prognostic marker in breast cancer and study its relation with established prognostic markers such as tumor grade, lymph node status, hormone receptor & HER-2/neu expression. We measured NF-κB expression of breast cancer tissue as a test sample & from fibroadenoma as a control. Measurement was done by Western Blot Technique using p65 protein of NF-κB super family of transcription factors. ER,PR and HER-2/neu were measured by immunohistochemistry methods. NF-κB/p65 is significantly associated with large tumor size (≥5 cm), high grade tumors, negative ER, negative PR, positive HER-2/neu and high NPI (≥5.4) scores. NF-κB/p65 expression implies aggressive biological behaviour of breast cancer & this study validates significant association of NF-κB /p65 overexpression with large tumor size, negative estrogen & progesterone receptor status and overexpression of c-erbB2 oncoprotein.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. Chen LF, Greene WC (2004) Shaping the nuclear action of NF-kappaB. Nat Rev Mol Cell Biol 5:392–401

    Article  PubMed  CAS  Google Scholar 

  2. Radhakrishnan SK, Kamalakaran S (2006) Pro-apoptotic role of NF-κB: implications for cancer therapy. Biochim Biophys Acta 1766:53–62

    PubMed  CAS  Google Scholar 

  3. Greten FR, Karin M (2004) The IKK/NF-kB activation pathway—a target for prevention. Cancer Lett 206:193–199

    Article  PubMed  CAS  Google Scholar 

  4. Van Laere SJ, Van der Auwera I, Van den Eynden GG, van Dam P, Van Marck EA, Vermeulen PB, Dirix LY (2007) NF-kB activation in inflammatory breast cancer is associated with oestrogen receptor downregulation, secondary to EGFR and/or ErbB2 overexpression and MAPK hyperactivation. Br J Cancer 97:659–669

    Article  PubMed  Google Scholar 

  5. Shostak K, Chariot A (2011) Breast Cancer Res 13:214

    Article  PubMed  Google Scholar 

  6. Ali S, Coombes C (2002) Nat Rev Mol Cell Biol 2:101–115

    Google Scholar 

  7. Kalkhoven E, Wissink S, van der Saag PT, van der Burg B (1996) J Biol Chem 271:6217–6224

    Article  PubMed  CAS  Google Scholar 

  8. Merkhofer EC, Cogswell P, Baldwin AS (2010) Her2 activates NF-κB and induces invasion through the canonical pathway involving IKKα. Oncogene 29:1238–1248

    Article  PubMed  CAS  Google Scholar 

  9. Sethi G, Sung B, Aggarwal BB (2008) Nuclear factor-κB activation: from bench to bedside. Exp Biol Med 233:21–31

    Article  CAS  Google Scholar 

  10. Zhou Y, Eppenberger-Castori S, Eppenberger U, Benz CC (2005) The NF-κB pathway and endocrine-resistant breast cancer. Endocr Relat Cancer 12:S37–S46

    Article  PubMed  CAS  Google Scholar 

  11. Zhoua Y, Eppenberger-Castorib S, Marxa C, Yaua C, Scotta GK, Eppenbergerb U, Benz CC (2005) Activation of nuclear factor-κB (NF-κB) identifies a high-risk subset of hormone-dependent breast cancers. Int J Biochem Cell Biol 37:1130–1144

    Article  Google Scholar 

  12. Biswas DK, Cruz AP, Gansberger E, Pardee AB (2000) Epidermal growth factor-induced nuclear factor kB activation: a major pathway of cell-cycle progression in estrogen-receptor negative breast cancer cells. PNAS 97(15):8542–8547

    Article  PubMed  CAS  Google Scholar 

  13. Nakshatri H, Bhat-Nakshatri P, Martin DA, Gouet RJ Jr, Sledge GW Jr (1997) Constitutive activation of NF-kB during progression of breast cancer to hormone-independent growth. Mol Cell Biol 17(7):3629–3639

    Google Scholar 

  14. Hou M-F, Lin S-B, Yuan S-SF, Tsai S-M, Wu S-H, Ou-Yang F, Hsieh J-S, Tsai K-B, Huang T-J, Tsai L-Y (2003) The clinical significance between activation of nuclear factor kappa B transcription factor and overexpression of HER-2/neu oncoprotein in Taiwanese patients with breast cancer. Clin Chim Acta 334:137–144

    Article  PubMed  CAS  Google Scholar 

  15. Balkwill F, Mantovani A (2001) Inflammation and cancer: back to Virchow? Lancet 357(9255):539–545

    Article  PubMed  CAS  Google Scholar 

  16. Karin M, Lin A (2002) NF-kappaB at the crossroads of life and death. Nat Immunol 3:221–227

    Article  PubMed  CAS  Google Scholar 

  17. Biswas DK, Martin KJ, McAlister C, Cruz AP, Graner E, Dai SC, Pardee AB (2003) Apoptosis caused by chemotherapeutic inhibition of nuclear factor-kappaB activation. Cancer Res 63:290–295

    PubMed  CAS  Google Scholar 

  18. Biswas DK, Dai S-C, Cruz A, Weiser B, Graner E, Pardee AB (2001) The nuclear factor kappa B (NF-kB): a potential therapeutic target for estrogen receptor negative breast cancers. PNAS 98:10386–10391

    Article  PubMed  CAS  Google Scholar 

  19. Nakshatri H, Bhat-Nakshatri P, Martin DA, Goulet RJ Jr, Sledge GW Jr (1997) Constitutive activation of NFkappaB during progression of breast cancer to hormone-independent growth. Mol Cell Biol 17:3629–3639

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to K. S. Chaudhari.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sarkar, D.K., Jana, D., Patil, P.S. et al. Role of NF-κB as a Prognostic Marker in Breast Cancer : A Pilot Study in Indian Patients. Indian J Surg Oncol 4, 242–247 (2013). https://doi.org/10.1007/s13193-013-0234-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13193-013-0234-y

Keywords

Navigation